The Health Care M&A Monthly: One Target, Two Buyers
We have recently seen a spate of deals with buyer and seller plodding through due diligence toward completion only to be caught off guard by an interloper intent on snagging the target for himself. A new offer is made, generally with better terms, that bumps the...The Health Care M&A Monthly: JNJ Cuts Offer By 15 Percent, Will Buy Guidant For $21.5 Billion
Last December we showcased 2004’s largest domestic transaction: Johnson & Johnson’s (NYSE: JNJ) purchase of medical device maker Guidant Corporation (NYSE: GDT) in a deal worth $25.4 billion. During the 11 months since its announcement, this deal has unfolded—and...The Health Care M&A Monthly: WellPoint Parries UnitedHealth, Buying WellChoice for $6.5 Billion
When UnitedHealth Group (NYSE: UNH) announced that it was buying PacifiCare Health Systems (NYSE: PHS) for $9.2 billion in July, we speculated that to shore up its dominant position, WellPoint (NYSE: WLP) would counter by acquiring New York’s WellChoice (NYSE: WC),...The Health Care M&A Monthly: Novartis Offers to Buy Rest of Chiron Corp. for $4.5 Billion
Influenza pandemics have been traveling the world long before globalization spread business and industry over the face of the earth. Western Europe is currently worried by the possibility of avian flu reaching it from Southeast Asia. And, as autumn approaches, we are...The Health Care M&A Monthly: Teva Stays on Top of Generics With $8 Billion Purchase of Ivax
Rapid consolidation among generic pharmaceutical companies is continuing through the sweltering days of the summer. Last month’s issue reported that Teva Pharmaceuticals (NASDAQ: TEVA) was on the prowl for an acquisition that would make it once again the largest...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
